Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202

Department of Tumor Biology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Oncogene (Impact Factor: 8.56). 02/1999; 18(3):807-11. DOI: 10.1038/sj.onc.1202369
Source: PubMed

ABSTRACT Interferons (IFNs) can exert cytostatic and immunomodulatory effects on carcinoma cells. In particular, growth inhibition of human prostate carcinoma by IFNs has been demonstrated both in vitro and in vivo. p202 is a 52 kd nuclear phosphoprotein known to be induced by IFNs. In this report, we showed that the expression of p202 was associated with an anti-proliferative effect on human prostate cancer cells. More importantly, cells that expressed p202 showed reduced ability to grow in soft-agar, indicating a loss of transformation phenotype. Our data suggest that p202 is a growth inhibitor gene in prostate cancer cells and its expression may also suppress transformation phenotype of prostate cancer cells.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Interferon-α2 (IFN-α2) has been tested extensively in human clinical trials and has proven to confer a survival benefit to patients with melanoma, renal cell carcinoma (RCC), chronic myelogenous leukemia (CML), hemangioma and various other malignancies. To date, the precise molecular determinants that differentiate responders from nonresponders have not been defined. A majority of the current knowledge about IFN-α2 has been derived from its role as an endogenously-produced antiviral compound. Importantly, new information on the activity of exogenously administered IFN-α is beginning to emerge as a result of its widespread use for tumor immunotherapy. This chapter will focus on the biology of IFN-α and its effects on downstream signaling events within the tumor cell and host immune effectors. We will highlight both endogenous and exogenous IFNα2, because information from each might provide insight into the mechanism of action of IFNα as an immunotherapeutic agent. Continued research on the basic biology of the IFN system could potentially lead to a greater understanding of its antitumor activity and greater clinical benefit while reducing its toxic side effects.
    12/2006: pages 339-372;
  • Source
    true, 01/2006: pages 129-132; Elsevier., ISBN: 0167-2991
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene mutation's role in initiating carcinogenesis has been controversial, but it is consensually accepted that both carcinogenesis and cancer metastasis are gene-regulated processes. MTA1, a metastasis-associated protein, has been extensively researched, especially regarding its role in cancer metastasis. In this review, I try to elucidate MTA1's role in both carcinogenesis and metastasis from a different angle. I propose that MTA1 is a stress response protein that is upregulated in various stress-related situations such as heat shock, hypoxia, and ironic radiation. Cancer cells are mostly living in a stressful environment of hypoxia, lack of nutrition, and immune reaction attacks. To cope with all these stresses, MTA1 expression is upregulated, plays a role of master regulator of gene expression, and helps cancer cells to survive and migrate out of their original dwelling.
    Cancer and metastasis reviews 10/2014; 33(4). DOI:10.1007/s10555-014-9525-1 · 6.45 Impact Factor

Full-text (2 Sources)

Available from
Nov 3, 2014